This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA weighs return of Zomax pain killer to market
The FDA considers reintroducing Zomax by Johnson & Johnson with new warnings and restricted uses for moderate to moderately severe pain. Advisory committee support hinges on labeling accepted by the agency and public protection through clearer reader warnings. The drug, linked to eight to fifteen deaths and 1,100 adverse reactions, was pulled March 4 after fatal and near fatal events.
MENTIONED IN THIS ARTICLE
FDA
Washington
Federal Food and Drug Administration
Johnson & Johnson
New Brunswick
N.J
Edward Nida
PDA
Nida
Zomax
Robert Andrews
McNeil Pharmaceutical
Andrews
Congress
Capitol Hill